查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1866523

全球聚合酵素链锁反应（PCR）市场－2025-2030年预测

Global Polymerase Chain Reaction (PCR) Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

聚合酵素链锁反应(PCR) 市场预计将从 2025 年的 115.21 亿美元成长到 2030 年的 164.86 亿美元，复合年增长率为 7.43%。

由于聚合酵素链锁反应(PCR) 在临床诊断、药物研发以及研究开发中扩增特定 DNA 区域方面发挥关键作用，全球 PCR 市场预计将迎来显着成长。 PCR 是一种体外技术，它利用耐热 Taq聚合酵素、DNA 引子、核苷酸碱基和缓衝液，透过热感循环（变性、退火和延伸步骤）产生数百万个 DNA 拷贝。过程重复 20 至 40 次，每次循环使 DNA 拷贝数翻倍，并以电泳进行检验。 PCR 广泛应用于分子生物学、医学诊断、法医学分析和生态学，仍是基因分析和检测的基础技术。

市场驱动因素

PCR技术在临床诊断中的应用日益广泛，尤其是在感染疾病和遗传性疾病的检测方面，是推动市场成长要素。其在生物标记鑑定和药物研发（包括个人化医疗）中的作用也促进了市场需求。试剂特异性的提高和PCR系统自动化等技术进步提高了效率和准确性，从而推动了市场成长。慢性疾病（包括癌症和代谢性疾病）盛行率的上升也推动了对PCR等先进诊断工具的需求，进而促进了市场扩张。

市场限制

PCR设备及相关耗材的高成本构成了一项重大挑战，尤其对于小规模的实验室和发展中地区的实验室而言更是如此。儘管该技术应用广泛，但这一成本壁垒可能会限制其普及化并抑制市场成长。

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

5. 全球聚合酵素链锁反应(PCR) 市场依产品类型划分

  • 介绍
  • 试剂
  • 装置
  • 消耗品
  • 软体和服务

6. 全球聚合酵素链锁反应(PCR) 技术市场

  • 介绍
  • 常规PCR
  • 即时PCR
  • 数位PCR
  • 其他的

7. 全球聚合酵素链锁反应(PCR) 市场依应用领域划分

  • 介绍
  • 临床诊断
  • 法医科学研究所
  • 生命科学研究
  • 环境测试
  • 食品安全与农业检验

8. 全球聚合酵素链锁反应(PCR) 市场（按地区划分）

  • 介绍
  • 北美洲
    • 依产品类型
    • 透过技术
    • 透过使用
    • 按国家/地区
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依产品类型
    • 透过技术
    • 透过使用
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依产品类型
    • 透过技术
    • 透过使用
    • 按国家/地区
      • 英国
      • 德国
      • 法国
      • 义大利
      • 其他的
  • 中东和非洲
    • 依产品类型
    • 透过技术
    • 透过使用
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 依产品类型
    • 透过技术
    • 透过使用
    • 按国家/地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 台湾
      • 其他的

第九章：竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章：公司简介

  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • Promega Corporation
  • bioMerieux SA
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation

第十一章 分析方法

简介目录
Product Code: KSI061611928

The Polymerase Chain Reaction (PCR) Market is set to grow from USD 11.521 billion in 2025 to USD 16.486 billion by 2030, registering a 7.43% CAGR.

The global polymerase chain reaction (PCR) market is poised for significant growth, driven by its critical role in amplifying specific DNA regions for applications in clinical diagnostics, drug development, and research. PCR, an in vitro technique utilizing thermostable Taq polymerase, DNA primers, nucleotide bases, and a buffer, enables the generation of millions of DNA copies through thermal cycling (denaturing, annealing, and extending stages). This process, repeated 20-40 times, doubles DNA copies per cycle and is validated using electrophoresis. Widely used in molecular biology, medical diagnostics, forensic analysis, and ecology, PCR remains a cornerstone of genetic research and testing.

Market Drivers

The increasing adoption of PCR in clinical diagnostics, particularly for detecting infectious diseases and genetic disorders, is a primary growth driver. Its role in drug development, including biomarker identification and personalized medicine, further fuels demand. Technological advancements, such as improved reagent specificity and automation of PCR systems, enhance efficiency and accuracy, boosting market growth. The rising prevalence of chronic diseases, including cancer and metabolic disorders, also drives demand for advanced diagnostic tools like PCR, supporting market expansion.

Market Restraints

The high cost of PCR instruments and associated consumables poses a significant challenge, particularly for smaller laboratories and facilities in developing regions. This cost barrier may limit adoption and restrain market growth despite the technology's widespread utility.

Market Segmentation

The PCR market is segmented by product type, end-user, and geography. By product type, it includes reagents, instruments, consumables, and software, with reagents expected to hold a significant share due to their high consumption and the variety of tests requiring specialized reagents. Innovations in reagent specificity are further driving this segment's growth. By end-user, the market covers pharmaceuticals and biopharmaceutical companies, diagnostic laboratories, and research institutes. The pharmaceutical and biotechnology sector is anticipated to see steady growth, fueled by ongoing advancements in drug development and personalized medicine. Geographically, the market spans North America, South America, Europe, the Middle East and Africa, and Asia-Pacific. North America is expected to maintain a strong market position due to its advanced healthcare infrastructure and high incidence of chronic diseases requiring sophisticated diagnostics. Asia-Pacific is projected to experience the fastest growth, driven by improved healthcare systems, increased investments in life sciences, and rising research activities.

Key Players

While specific companies are not named, major players in the PCR market are likely focusing on innovation, such as developing high-specificity reagents and automated PCR systems, to strengthen their market positions. Strategic partnerships and investments in research and development are key to addressing evolving diagnostic and research needs.

Market Insights

The market analysis highlights trends in demand, supply, and technological advancements, supported by comprehensive segmentation and regional forecasts. The growing emphasis on precision medicine and early disease detection underscores PCR's importance, particularly in North America and Asia-Pacific. Despite cost-related challenges, the market is set to grow as healthcare investments and technological innovations continue to drive adoption.

In conclusion, the PCR market is positioned for robust growth, propelled by its critical applications in diagnostics and drug development, advancements in reagent technology, and regional healthcare improvements. North America and Asia-Pacific are key growth regions, though high costs may temper expansion. Industry leaders are leveraging innovation to meet rising demand, ensuring PCR remains integral to modern medical and research advancements.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Product Type

  • Reagents
  • Instruments
  • Consumables
  • Software & Services

By Technology

  • Conventional PCR
  • Real-Time PCR
  • Digital PCR
  • Others

By Application

  • Clinical Diagnosis
  • Forensic Laboratories
  • Life Science Research
  • Environmental Testing
  • Food Safety and Agricultural Testing

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. POLYMERASE CHAIN REACTION (PCR) MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Reagents
  • 5.3. Instruments
  • 5.4. Consumables
  • 5.5. Software & Services

6. POLYMERASE CHAIN REACTION (PCR) MARKET TECHNOLOGY

  • 6.1. Introduction
  • 6.2. Conventional PCR
  • 6.3. Real-Time PCR
  • 6.4. Digital PCR
  • 6.5. Others

7. POLYMERASE CHAIN REACTION (PCR) MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Clinical Diagnosis
  • 7.3. Forensic Laboratories
  • 7.4. Life Science Research
  • 7.5. Environmental Testing
  • 7.6. Food Safety and Agricultural Testing

8. POLYMERASE CHAIN REACTION (PCR) MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Technology
    • 8.3.3. By Application
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Technology
    • 8.4.3. By Application
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Others
  • 8.5. Middle East & Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Technology
    • 8.5.3. By Application
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Technology
    • 8.6.3. By Application
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Thermo Fisher Scientific Inc.
  • 10.2. Abbott Laboratories
  • 10.3. Agilent Technologies, Inc.
  • 10.4. Siemens Healthineers AG
  • 10.5. Becton, Dickinson and Company
  • 10.6. Promega Corporation
  • 10.7. bioMerieux SA
  • 10.8. Merck KGaA
  • 10.9. Bio-Rad Laboratories, Inc.
  • 10.10. GE Healthcare
  • 10.11. QIAGEN N.V.
  • 10.12. F. Hoffmann-La Roche Ltd.
  • 10.13. Danaher Corporation

11. RESEARCH METHODOLOGY